Status:
UNKNOWN
Establishment of Prevention and Control System of Central Nervous System Infection
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Central Nervous System (CNS) Infection
Encephalitis
Eligibility:
All Genders
18+ years
Brief Summary
Central nervous system (CNS) infection is a common nervous system acute and severe disease, mainly manifested as encephalitis, meningitis and meningoencephalitis, but also manifested as brain abscess ...
Eligibility Criteria
Inclusion
- Clinical suspected encephalitis or meningitis; onset time within 1 month; modified Rankin Scale (MRS) \< 2 points before onset; informed consent of patients; patients who can not express their personal wishes due to aphasia, disturbance of consciousness and other reasons need to obtain the informed consent of their authorized relatives.
Exclusion
- Non.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
715 Patients enrolled
Trial Details
Trial ID
NCT04722328
Start Date
March 1 2021
End Date
December 31 2025
Last Update
January 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital
Beijing, China